HOME >> BIOLOGY >> NEWS
BioMed Central applauds Wellcome's leadership on Open Access

Publisher BioMed Central today congratulated the Wellcome Trust on its move to require researchers receiving Wellcome funding to deposit copies of resulting research articles in an Open Access archive. The Trust announced its Open Access policy on 19 May.

"For too long, funders have stood by as the results of scientific and medical research have been handed over to traditional publishers, who have then put those research articles behind subscription barriers," said Matthew Cockerill, Director of Operations at BioMed Central. "Subscription-only access to research does not meet the needs of researchers, funders, or the general public, all of whom benefit from the widest possible access to research findings, which is what Open Access delivers."

"Following on from the National Institutes of Health's similar initiative in the USA, Wellcome's move shows that the funders who spend hundreds of millions of pounds to carry out the research in the first place are no longer prepared to see their research results remain inaccessible."

The Wellcome Trust is the UK's biggest non-governmental funder of biomedical research with an annual spend of 400 million. The recipients of Wellcome's funding produce almost 3500 scientific articles each year. With such a major funding body backing Open Access, it is now expected that other funding bodies around the world will follow suit.

Wellcome's policy specifies that articles must be made freely available within, at most, six months of initial publication, but BioMed Central called on researchers to go further and to make their research accessible immediately on publication, by choosing an Open Access journal."

"Six months is a long time in science with the rapid pace of research, quick access to the latest results is vital. So, the best way for researchers to meet the spirit of the Wellcome policy is to publish in fully Open Access journals, such as those published by BioMed Central."

Publishi
'"/>

Contact: Grace Baynes
press@biomedcentral.com
44-20-7631-9988
BioMed Central
25-May-2005


Page: 1 2

Related biology news :

1. BioMed Central announces new interdisciplinary Biofuels Journal
2. BioMed Central announces winners of first open access research awards
3. BioMed Central launches BMC Systems Biology, a new open access journal
4. Impressive new Impact Factors for BioMed Centrals open-access journals
5. BioMed Central launches Biology Direct
6. BioMed Central welcomes the new National Institutes of Health public access policy
7. BioMed Central announces publishing partnership with The Scientist magazine
8. Woods Hole Research Center scientists study impacts of industrial logging in Central Africa
9. Central and peripheral signals set the circadian liver clock
10. Announcing the launch of Open Access Central
11. EMBL-EBI and collaborators win bid to run UK PubMed Central

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: BioMed Central applauds Wellcome leadership Open Access

(Date:10/22/2014)... (NASDAQ: AWRE ), a leading supplier of biometrics ... quarter ended September 30, 2014. Revenue for the ... 40% compared to $4.3 million in the same quarter last ... $4.1 million compared to $1.0 million in the third quarter ... period was primarily due to: i) a $1.0 million increase ...
(Date:10/18/2014)... stress and stress-related psychiatric disorders are associated ... the molecular mechanisms underlying this relation are ... the development of targeted preventive strategies and ... diseases. This work is presented at the ... Now an international group of researchers from ...
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7Researchers find why depression and aging linked to increased disease risk 2Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3
(Date:10/25/2014)... 2014 Today, Nerium International, a leader ... of its “Reflect Your Youth” contest, an effort launched ... a difference in their skin since using Nerium’s product ... on life as a result of their newfound confidence. ... effort by Nerium International to inspire conversations focused on ...
(Date:10/25/2014)... , October 24, 2014 Oramed ... pharmaceutical company focused on the development of oral drug ... Nadav Kidron will present at FireRock Capital,s Micro-Cap ... Annual Micro-Cap Conference ,Date: Tuesday, October 28, 2014 ,Time: ... New York City , ...
(Date:10/25/2014)... 24, 2014 Research and Markets ... by Product , Research Area & by End User ... offering. In this report, the global ... research areas, and end users. The product segments of ... instruments & consumables, kits, and reagents. The subsegments of ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis plc ... pharmaceutical company, and Rhythm, a biopharmaceutical company, today announced ... acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., which ... the treatment of diabetic gastroparesis and other GI functional ... Phase 2 trial of relamorelin for the treatment of ...
Breaking Biology Technology:Nerium International™ Inspires Conversation About the Journey of Aging with “Reflect Your Youth” Contest 2Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019 2Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5
Cached News: